[go: up one dir, main page]

WO2009005124A1 - 乳酸菌由来の２本鎖ｒｎａ - Google Patents

乳酸菌由来の２本鎖ｒｎａ Download PDF

Info

Publication number
WO2009005124A1
WO2009005124A1 PCT/JP2008/062066 JP2008062066W WO2009005124A1 WO 2009005124 A1 WO2009005124 A1 WO 2009005124A1 JP 2008062066 W JP2008062066 W JP 2008062066W WO 2009005124 A1 WO2009005124 A1 WO 2009005124A1
Authority
WO
WIPO (PCT)
Prior art keywords
double
lactic acid
stranded rna
acid bacterium
rna originating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/062066
Other languages
English (en)
French (fr)
Inventor
Ikuko Masuda
Daisuke Kaneko
Tadaomi Kawashima
Noriko Tsuji
Akemi Kosaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kikkoman Corp
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
Kikkoman Corp
National Institute of Advanced Industrial Science and Technology AIST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kikkoman Corp, National Institute of Advanced Industrial Science and Technology AIST filed Critical Kikkoman Corp
Priority to EP08777818.9A priority Critical patent/EP2169057B1/en
Priority to JP2009521668A priority patent/JP5099649B2/ja
Priority to CN200880105541A priority patent/CN101796187A/zh
Priority to US12/452,405 priority patent/US8334371B2/en
Priority to CA2694354A priority patent/CA2694354C/en
Publication of WO2009005124A1 publication Critical patent/WO2009005124A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/17—Immunomodulatory nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/10—Production naturally occurring

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

　安全で、かつ、細胞に効率的に取り込まれる免疫調節剤及びその製造法を提供すること。 　乳酸菌由来の２本鎖ＲＮＡ、乳酸菌由来の２本鎖ＲＮＡを有効成分とする免疫調節剤及び乳酸菌由来の２本鎖ＲＮＡの製造法を提供する。乳酸菌の一種であるテトラジェノコッカス属、ペディオコッカス属、ラクトバチルス属、ストレプトコッカス属、ロイコノストック属などの菌体が、免疫調節作用を有する２本鎖ＲＮＡを菌体中に生産することができる。
PCT/JP2008/062066 2007-07-04 2008-07-03 乳酸菌由来の２本鎖ｒｎａ Ceased WO2009005124A1 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP08777818.9A EP2169057B1 (en) 2007-07-04 2008-07-03 Double-stranded rna originating in lactic acid bacterium
JP2009521668A JP5099649B2 (ja) 2007-07-04 2008-07-03 乳酸菌由来の２本鎖ｒｎａ
CN200880105541A CN101796187A (zh) 2007-07-04 2008-07-03 乳酸菌来源的双链rna
US12/452,405 US8334371B2 (en) 2007-07-04 2008-07-03 Lactic acid bacteria-derived double-stranded RNA
CA2694354A CA2694354C (en) 2007-07-04 2008-07-03 Lactic acid bacteria-derived double-stranded rna

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007175694 2007-07-04
JP2007-175694 2007-07-04
JP2007299243 2007-11-19
JP2007-299243 2007-11-19

Publications (1)

Publication Number Publication Date
WO2009005124A1 true WO2009005124A1 (ja) 2009-01-08

Family

ID=40226165

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/062066 Ceased WO2009005124A1 (ja) 2007-07-04 2008-07-03 乳酸菌由来の２本鎖ｒｎａ

Country Status (6)

Country Link
US (1) US8334371B2 (ja)
EP (1) EP2169057B1 (ja)
JP (1) JP5099649B2 (ja)
CN (1) CN101796187A (ja)
CA (1) CA2694354C (ja)
WO (1) WO2009005124A1 (ja)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011027829A1 (ja) * 2009-09-02 2011-03-10 京都府公立大学法人 乳酸菌由来のｒｎａを有効成分とする組成物
WO2015004949A1 (ja) 2013-07-12 2015-01-15 森永乳業株式会社 新規乳酸菌、並びに新規乳酸菌を含有する医薬、飲食品、及び飼料
US9549956B2 (en) 2010-12-28 2017-01-24 Kirin Holdings Kabushiki Kaisha Agent for inducing interferon production containing lactic acid bacteria
JP2017112901A (ja) * 2015-12-24 2017-06-29 キッコーマン株式会社 高分子ヒアルロン酸の製造方法
WO2017175774A1 (ja) * 2016-04-04 2017-10-12 キッコーマン株式会社 インターフェロンλ産生促進用組成物及びその製造方法
JP2018016580A (ja) * 2016-07-27 2018-02-01 株式会社東洋発酵 免疫賦活組成物
JP2018048087A (ja) * 2016-09-21 2018-03-29 アダプトゲン製薬株式会社 体重又は内臓脂肪増加抑制剤若しくは体重又は内臓脂肪増加抑制用食品組成物若しくは体重又は内臓脂肪増加抑制用飼料組成物
WO2018207924A1 (ja) * 2017-05-12 2018-11-15 キッコーマン株式会社 二本鎖ｒｎａ高含有乳酸菌の製造方法及び該乳酸菌
US11241463B2 (en) 2013-07-12 2022-02-08 Morinaga Milk Industry Co., Ltd. Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013025248A1 (en) * 2011-08-12 2013-02-21 Mello Biotechnology, Inc. Inducable expression from the eukaryotic pol -2 promoter in prokaryotes
CN102935238A (zh) * 2012-07-27 2013-02-20 水爱生物科技（南通）有限公司 一种酵母M-dsRNA作为TLR3激动剂的应用及其制备方法
US10196662B2 (en) * 2012-08-10 2019-02-05 Mello Biotechnology, Inc. Composition for producing microRNA precursors as drugs for enhancing wound healing and production method of the microRNA precursors
CN105779442B (zh) * 2016-05-19 2019-05-28 清华大学 一种天然纤维素利用菌群的宏转录组rna的提取方法
KR102698401B1 (ko) 2016-09-12 2024-08-26 이치비키 가부시키가이샤 내염성 유산균, 내염성 유산균의 배양 방법, 및 면역 부활제

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006232790A (ja) * 2005-02-28 2006-09-07 Meiji Milk Prod Co Ltd Ａｔオリゴヌクレオチドを有効成分とする免疫応答増強性薬剤及び食品組成物
JP2006325540A (ja) * 2005-05-30 2006-12-07 Takanashi Milk Products Co Ltd オリゴデオキシヌクレオチドおよびこれを利用する免疫修飾剤

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0680575A (ja) 1991-03-05 1994-03-22 Meiji Milk Prod Co Ltd 経口免疫賦活剤
JP3174611B2 (ja) 1992-02-28 2001-06-11 明治乳業株式会社 免疫賦活組成物
JP4112021B2 (ja) 1994-02-16 2008-07-02 明治乳業株式会社 乳酸菌を用いた免疫賦活剤
JPH0899887A (ja) 1994-08-01 1996-04-16 Nichinichi Seiyaku Kk 免疫賦活剤
JPH092959A (ja) 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
JPH09124496A (ja) 1995-10-31 1997-05-13 Nichinichi Seiyaku Kk 感染防御剤
JPH09188627A (ja) 1996-01-10 1997-07-22 Kyoto Pasutouule Kenkyusho インターフェロン産生能向上物質及びその製造方法
JP3040711B2 (ja) 1996-02-21 2000-05-15 ニチニチ製薬株式会社 抗腫瘍剤及びその製造法
JP4064481B2 (ja) 1996-10-11 2008-03-19 ハウスウェルネスフーズ株式会社 免疫賦活剤
JPH10309178A (ja) 1997-05-09 1998-11-24 Wakamoto Pharmaceut Co Ltd ビフィズス菌を有効成分とする抗アレルギー剤および醗酵食品
JP2000095697A (ja) 1998-09-18 2000-04-04 Advance Co Ltd 抗アレルギー剤
JP2003113114A (ja) 2001-10-09 2003-04-18 Nichimo Co Ltd 免疫賦活素材
JP4308481B2 (ja) 2002-06-18 2009-08-05 独立行政法人農業・食品産業技術総合研究機構 抗アレルギー剤
JP4212838B2 (ja) 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
DE602005018237D1 (de) 2004-05-28 2010-01-21 Suntory Holdings Ltd Zusammensetzung mit immunregulierenden wirkungen aus lactobacillus pentosus
JP2006028047A (ja) 2004-07-14 2006-02-02 Kikkoman Corp インターロイキン１２産生促進剤およびその製造法
US20110256611A1 (en) * 2007-04-03 2011-10-20 Tadaomi Kawashima Interferon beta production promoter and a method for producing thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006232790A (ja) * 2005-02-28 2006-09-07 Meiji Milk Prod Co Ltd Ａｔオリゴヌクレオチドを有効成分とする免疫応答増強性薬剤及び食品組成物
JP2006325540A (ja) * 2005-05-30 2006-12-07 Takanashi Milk Products Co Ltd オリゴデオキシヌクレオチドおよびこれを利用する免疫修飾剤

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ICHIKAWA S. ET AL.: "MyD88 but Not TLR2, 4 or 9 Is Essential for IL-12 Induction by Lactic Acid Bacteria", BIOSCI. BIOTECHNOL. BIOCHEM., vol. 71, no. 12, December 2007 (2007-12-01), pages 3026 - 3032, XP008128031 *
KITAZAWA H. ET AL.: "AT Oligonucleotides Inducing B Lymphocyte Activation Exist in Probiotic Lactobacillus gasseri", INT. J. FOOD MICROBIOL., vol. 65, no. 3, 2001, pages 149 - 162, XP003002302 *
KITAZAWA H. ET AL.: "IMmunostimulatory Oligonucleotide, CpG-like Motif Exists in Lactobacillus delbrueckii ssp. bulgaricus NIAI B6", INT. J. FOOD MICROBIOL., vol. 85, no. 1-2, 2003, pages 11 - 21, XP008128035 *
MASUDA S. ET AL.: "Immunomodulatory Effect of Halophilic Lactic Acid Bacterium Tetragenococcus halophilus Th221 from Soy Sauce Moromi Grown in High-salt Medium", INT. J. FOOD MICROBIOL., vol. 121, no. 3, February 2008 (2008-02-01), pages 245 - 252, XP022439569 *
NISHIMURA I.: "Tetragenococcus halophilus KK221 Kabu (Th221 Kabu) no Nihonsa RNA wa TLR3 o Kaishite Kogen Teiji Saibo Karano IL-12 Sansei o Yudo suru", JOURNAL OF JAPAN SOCIETY FOR LACTIC ACID BACTERIA, vol. 19, no. 2, June 2008 (2008-06-01), pages 117 *
TAKAHASHI N. ET AL.: "An Immunostimulatory DNA Sequence from a Probiotic Strain of Bifidobacterium longum Inhibits IgE Production in vitro", FEMS IMMUNOL. MED. MICROBIOL., vol. 46, no. 3, 2006, pages 461 - 469, XP009069320 *

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2011027829A1 (ja) * 2009-09-02 2013-02-04 京都府公立大学法人 乳酸菌由来のｒｎａを有効成分とする組成物
US8765706B2 (en) 2009-09-02 2014-07-01 Kyoto Prefectural Public University Corporation Composition comprising rna derived from lactic acid bacterium as effective component
WO2011027829A1 (ja) * 2009-09-02 2011-03-10 京都府公立大学法人 乳酸菌由来のｒｎａを有効成分とする組成物
US10220060B2 (en) 2010-12-28 2019-03-05 Kirin Holdings Kabushiki Kaisha Agent for inducing interferon production containing lactic acid bacteria
US12485150B2 (en) 2010-12-28 2025-12-02 Kirin Holdings Kabushiki Kaisha Agent for inducing interferon production containing lactic acid bacteria
US9549956B2 (en) 2010-12-28 2017-01-24 Kirin Holdings Kabushiki Kaisha Agent for inducing interferon production containing lactic acid bacteria
US11944657B2 (en) 2010-12-28 2024-04-02 Kirin Holdings Kabushiki Kaisha Agent for inducing interferon production containing lactic acid bacteria
US11224623B2 (en) 2010-12-28 2022-01-18 Kirin Holdings Kabushiki Kaisha Agent for inducing interferon production containing lactic acid bacteria
US10653730B2 (en) 2013-07-12 2020-05-19 Morinaga Milk Industry Co., Ltd. Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium
US10064903B2 (en) 2013-07-12 2018-09-04 Morinaga Milk Industry Co., Ltd. Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium
WO2015004949A1 (ja) 2013-07-12 2015-01-15 森永乳業株式会社 新規乳酸菌、並びに新規乳酸菌を含有する医薬、飲食品、及び飼料
US11241463B2 (en) 2013-07-12 2022-02-08 Morinaga Milk Industry Co., Ltd. Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium
WO2017110421A1 (ja) * 2015-12-24 2017-06-29 キッコーマン株式会社 高分子ヒアルロン酸の製造方法
JP2017112901A (ja) * 2015-12-24 2017-06-29 キッコーマン株式会社 高分子ヒアルロン酸の製造方法
JPWO2017175774A1 (ja) * 2016-04-04 2019-02-21 キッコーマン株式会社 インターフェロンλ産生促進用組成物及びその製造方法
WO2017175774A1 (ja) * 2016-04-04 2017-10-12 キッコーマン株式会社 インターフェロンλ産生促進用組成物及びその製造方法
JP2021107446A (ja) * 2016-07-27 2021-07-29 株式会社東洋発酵 免疫賦活組成物
JP2018016580A (ja) * 2016-07-27 2018-02-01 株式会社東洋発酵 免疫賦活組成物
JP7165363B2 (ja) 2016-07-27 2022-11-04 株式会社東洋発酵 免疫賦活組成物
JP2018048087A (ja) * 2016-09-21 2018-03-29 アダプトゲン製薬株式会社 体重又は内臓脂肪増加抑制剤若しくは体重又は内臓脂肪増加抑制用食品組成物若しくは体重又は内臓脂肪増加抑制用飼料組成物
JP6480090B1 (ja) * 2017-05-12 2019-03-06 キッコーマン株式会社 二本鎖ｒｎａ高含有乳酸菌の製造方法及び該乳酸菌
US11518976B2 (en) 2017-05-12 2022-12-06 Kikkoman Corporation Method for producing double-stranded RNA-rich lactic acid bacterium, and said lactic acid bacterium
WO2018207924A1 (ja) * 2017-05-12 2018-11-15 キッコーマン株式会社 二本鎖ｒｎａ高含有乳酸菌の製造方法及び該乳酸菌

Also Published As

Publication number Publication date
CN101796187A (zh) 2010-08-04
US20110159552A1 (en) 2011-06-30
CA2694354C (en) 2018-01-16
JP5099649B2 (ja) 2012-12-19
EP2169057B1 (en) 2015-09-30
US8334371B2 (en) 2012-12-18
EP2169057A1 (en) 2010-03-31
CA2694354A1 (en) 2009-01-08
EP2169057A4 (en) 2010-07-28
JPWO2009005124A1 (ja) 2010-08-26

Similar Documents

Publication Publication Date Title
WO2009005124A1 (ja) 乳酸菌由来の２本鎖ｒｎａ
WO2014018596A3 (en) Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides
WO2007116955A3 (en) Method for producing l-amino acid
WO2009095436A3 (en) Non-pathogenic and/or attenuated bacteria capable of inducing apoptosis in macrophages, process of manufacturing and uses thereof
WO2010064930A8 (en) Use of lactic acid bacteria to treat or prevent eczema
WO2008129841A1 (ja) 高抗アレルギー活性を有する乳酸菌組成物及び該乳酸菌の製造方法
WO2008099543A1 (ja) 新規乳酸菌を用いた発酵乳の製造方法
WO2008073841A3 (en) Lactobacillus buchneri strain ln1297 and its use to improve aerobic stability of silage
MX2013011626A (es) Efecto antimicrobiano sinergico.
WO2012071392A8 (en) Engineering of thermotolerant bacillus coagulans for production of d(-)-lactic acid
DK2062968T3 (da) Bakteriestamme med anti-allergisk aktivitet, og drikkevare, fødevare og anti-allergimiddel omfattende celle af bakteriestammen
CA2710820A1 (en) Method for producing fermented milk
UA86349C2 (ru) Противоаллергический агент, его применение для снижения аллергии и способ уменьшения симптомов аллергии
EP1812023B8 (en) Lactic acid bacteria as probiotic strains and compositions containing same
WO2008073853A8 (en) Lactobacillus buchneri strain ln5689 and its use to improve aerobic stability of silage
WO2010101855A3 (en) Microbial derived isoprene and methods for making the same
EP1700910A3 (en) Purine-derived substance-producing Bacillus and a method for producing purine-derived substance therewith
WO2009008656A3 (en) A soap composition for atopic dermatitis containing fermented extract of xanthium strumarium l. and preparation method thereof
WO2008073839A3 (en) Lactobacillus buchneri strain ln1286 and its use to improve aerobic stability of silage
WO2011048554A3 (fr) Association d'un lysat de probiotique et d'un derive c-glycoside
WO2009005123A1 (ja) インターフェロンβ産生促進剤及びその製造法
WO2010034974A3 (en) Tuberculosis vaccines targeted to cd40
WO2010103548A3 (en) Improved method for producing lactic acid and derivative thereof
WO2008099801A1 (ja) 乳酸菌生残性向上剤
WO2013026886A3 (en) Microorganisms of the species bacteroides xylanisolvens

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880105541.3

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2009521668

Country of ref document: JP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08777818

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2694354

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008777818

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12452405

Country of ref document: US